uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)
Close on Nov 18, 2026Market cap $1.41BP/E –Yield –
uniQure pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
uniQure's pe ratio was 3.7× on Jul 29, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 3.7× | +0.6 |
| 2021 | Dec 31, 2021 | 3.1× | – |
See a number that looks wrong?